Drug delivery for ocular and neurodegenerative diseases; Nanomedicine
Kannan Rangaramanujam, Ph.D., is a professor of ophthalmology and co-director of the Center for Nanomedicine at the Wilmer Eye Institute at Johns Hopkins School of Medicine. His research spans a wide range of nanomaterial applications, including nanomedicine and nanocomposites. He has initiated an interdisciplinary translational research program based on dendrimers, with a specific focus on targeted drug delivery for ocular and neurodegenerative diseases such as cerebral palsy and age-related macular degeneration. Dr. Rangaramanujam is an author of four patents and more than 80 peer-reviewed publications. He has won several recognitions, including the National Science Foundation CAREER and Unilever awards, and serves on the editorial board of Nanomedicine.
Dr. Rangaramanujam received his Ph.D. in chemical engineering from the California Institute of Technology and completed a postdoctoral fellowship at the University of Minnesota. After two years as a senior research engineer at 3M Corporate Research, he joined the faculty of Wayne State University in Detroit, Michigan as a professor of chemical engineering, materials science and biomedical engineering. He joined the Hopkins faculty in 2011.